MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer
Clinical trial NCT05462236 · RECRUITING
Trial details
- NCT number
- NCT05462236
- Sponsor
- AUM Biosciences Pte Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-14
- Primary completion
- 2024-09-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.